semaglutide appendicitis Patient Basics: Mother, 58, suffered 'burst appendix'

Target audience is GLP-1 Aware: We chose to focus on the 144M people who already had some awareness of GLP-1s (GLP-1 Aware) and who might be interested in the treatment for themselves or their loved ones

Patient has received sedating medications (especially benzodiazepine): Only a relative contraindication

In recent years, GLP1-based treatments for obesity have evolved from being primarily a diabetes-focused strategy to becoming a powerful tool for managing weight and reducing cardiometabolic riskespecially in individuals without type 2 diabetes

N Engl J Med 376:641651 Mller TD, Blher M, Tschp MH, DiMarchi RD (2022) Anti-obesity drug discovery: advances and challenges

Let's delve into "what insurance covers Wegovy" and ensure you have complete clarity